Macrogenics Inc
MGNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001125345
In the last 90 days, Macrogenics Inc insiders filed 0 open-market purchases and 1 sale; 122 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Macrogenics Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +1 vs. Q4 2024
- Shares held
- 53.8M
- −2.12M (−3.8%) vs. Q4 2024
- Total value
- $68.3M
- −$113.5M (−62.4%) vs. Q4 2024
- New holders
- 19
- 36 more added
- Sold out
- 18
- 42 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $224.9M |
| Q1 2026 | 109 | $124.8M |
| Q4 2025 | 89 | $64.3M |
| Q3 2025 | 104 | $77.4M |
| Q2 2025 | 112 | $58.5M |
| Q1 2025 | 129 | $68.3M |
| Q4 2024 | 129 | $182.5M |
| Q3 2024 | 124 | $187.9M |
| Q2 2024 | 147 | $258.9M |
| Q1 2024 | 163 | $953.6M |
| Q4 2023 | 143 | $595.1M |
| Q3 2023 | 127 | $270.5M |
| Q2 2023 | 131 | $321.1M |
| Q1 2023 | 137 | $419.1M |
| Q4 2022 | 135 | $380.5M |
| Q3 2022 | 135 | $199.0M |
| Q2 2022 | 133 | $184.9M |
| Q1 2022 | 144 | $531.2M |
| Q4 2021 | 156 | $918.1M |
| Q3 2021 | 154 | $1.21B |
| Q2 2021 | 149 | $1.54B |
| Q1 2021 | 174 | $1.80B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Macrogenics Inc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AQR Capital Management LLC | 232,399 | $295.1K | 0.00% | −86,671−27.2% | Reduced |
| Jane Street Group, LLC | 246,427 | $313.0K | 0.00% | −207,910−45.8% | Reduced |
| FMR LLC | 248,235 | $315.3K | 0.00% | +73,739+42.3% | Added |
| Vestal Point Capital, LP | 280,000 | $355.6K | 0.03% | 00.0% | Unchanged |
| Marshall Wace, LLP | 299,028 | $379.8K | 0.00% | −94,738−24.1% | Reduced |
| Morgan Stanley | 341,485 | $433.7K | 0.00% | −762,941−69.1% | Reduced |
| Macquarie Group Ltd | 420,000 | $533.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 448,530 | $570.0K | 0.05% | +201,926+81.9% | Added |
| Pinnacle Associates Ltd | 476,496 | $605.1K | 0.01% | −25,354−5.1% | Reduced |
| Northern Trust Corp | 521,269 | $662.0K | 0.00% | −19,701−3.6% | Reduced |
| Charles Schwab Investment Management Inc | 525,535 | $667.4K | 0.00% | −1,650−0.3% | Reduced |
| Dimensional Fund Advisors LP | 645,625 | $819.8K | 0.00% | −71,663−10.0% | Reduced |
| Two Sigma Investments, LP | 654,898 | $831.7K | 0.00% | −205,847−23.9% | Reduced |
| Jacobs Levy Equity Management, Inc | 665,351 | $845.0K | 0.00% | +99,447+17.6% | Added |
| JPMorgan Chase & Co | 745,062 | $946.2K | 0.00% | +198,255+36.3% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 816,054 | $1.04M | 0.00% | +71,152+9.6% | Added |
| Two Sigma Advisers, LP | 1,068,200 | $1.36M | 0.00% | −50,400−4.5% | Reduced |
| Rock Springs Capital Management LP | 1,145,214 | $1.45M | 0.08% | +91,567+8.7% | Added |
| Renaissance Technologies LLC | 1,152,270 | $1.46M | 0.00% | +613,747+114.0% | Added |
| State Street Corp | 1,409,312 | $1.79M | 0.00% | −53,220−3.6% | Reduced |
| Geode Capital Management, LLC | 1,456,188 | $1.85M | 0.00% | +22,971+1.6% | Added |
| Millennium Management LLC | 1,724,250 | $2.19M | 0.00% | −1,140,471−39.8% | Reduced |
| Acadian Asset Management LLC | 2,308,649 | $2.92M | 0.01% | +1,017,726+78.8% | Added |
| Frazier Life Sciences Management, L.P. | 3,175,665 | $4.03M | 0.18% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 3,250,248 | $4.13M | 0.02% | −238,245−6.8% | Reduced |
| Vanguard Group Inc | 4,425,992 | $5.62M | 0.00% | +109,311+2.5% | Added |
| BlackRock, Inc. | 4,913,128 | $6.24M | 0.00% | −144,047−2.8% | Reduced |
| Armistice Capital, LLC | 6,296,000 | $8.00M | 0.21% | +20,000+0.3% | Added |
| Bellevue Group AG | 9,929,963 | $12.6M | 0.28% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −857,505−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −323,857−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −255,745−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −111,993−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −66,742−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −43,400−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −38,353−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −27,410−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −27,389−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −18,097−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −12,921−100.0% | Sold out |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −11,281−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1,707−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −1,088−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −570−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |